Bisphosphonate related osteonecrosis of the jaws: clinico-pathological investigation and histomorphometric analysis

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 May;115(5):660-6. doi: 10.1016/j.oooo.2013.03.001.

Abstract

Objectives: Clinico-pathological evaluation of bisphosphonate (BP)-related osteonecrosis of jaws, comparison between oral (PO) and intravenous (IV) BPs and histomorphometric analysis of associated actinomyces.

Study design: Retrospective clinical and histomorphometric analysis. Data on background, clinical, treatment and follow-up were analyzed. Actinomyces colonies were identified by typical filamentous colony morphology, Gram, and PAS stains. Colony density and relative colony surface area were measured.

Results: Fifty-two patients were included, 37 (71.2%) IV, 15 (28.8%) PO BPs. with a mean duration of 2.33 and, 4.33 years respectively. One hundred percent of cases exhibited actinomyces colonization. The relative colony surface area was significantly higher in PO treatment (P = .024), with no differences in density, healing time or antibiotic treatment periods. High frequency of diabetes mellitus (60% PO cases) and corticosteroid treatment (25% of cases) were recorded.

Conclusion: Infection with actinomyces is a common denominator in BP-related osteonecrosis of the jaws (BRONJ), regardless of administration route. Diabetes and corticosteroid treatment seem to be important contributing factors for BRONJ.

Publication types

  • Comparative Study

MeSH terms

  • Actinomyces / isolation & purification
  • Actinomycosis / epidemiology*
  • Administration, Intravenous
  • Administration, Oral
  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Antineoplastic Agents / administration & dosage
  • Bacterial Load
  • Bisphosphonate-Associated Osteonecrosis of the Jaw / epidemiology*
  • Bisphosphonate-Associated Osteonecrosis of the Jaw / microbiology
  • Breast Neoplasms / drug therapy
  • Diabetes Complications / epidemiology
  • Diphosphonates / administration & dosage
  • Diphosphonates / adverse effects
  • Female
  • Follow-Up Studies
  • Humans
  • Israel / epidemiology
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy
  • Osteomyelitis / epidemiology
  • Osteomyelitis / microbiology
  • Osteoporosis / drug therapy
  • Prostatic Neoplasms / drug therapy
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Wound Healing / physiology

Substances

  • Adrenal Cortex Hormones
  • Anti-Bacterial Agents
  • Antineoplastic Agents
  • Diphosphonates